Wegovy maker Novo Nordisk down 4%, heads for worst day since October
Analysts pored over the details in its first-quarter results and monitored a potential rival weight loss treatment.
Source link
Analysts pored over the details in its first-quarter results and monitored a potential rival weight loss treatment.
Source link
/cloudfront-us-east-2.images.arcpublishing.com/reuters/C6RIZMUTIJKHDGBDKSGWV62IEA.jpg "EXCLUSIVE U.S. asks Japan, China, others to consider tapping oil reserves -sources")
